Aspirin reduces risk of recurrence in patients with unprovoked venous thromboembolism
Aspirin for preventing the recurrence of venous thromboembolismN Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Two weeks following the completion of treatment with vitamin K antagonists, 403 patients with a previous unprovoked venous thromboembolism (VTE) were randomised into two groups. Patients either received 100 mg aspirin or a placebo, once per day for 2 years, to measure the recurrence of VTE. Following assessments every 3 months in the first year and every 6 months in the second year, the results de...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE